Market Capitalization of Cohance Lifesciences (COHANCE)
As of July 24, 2026, Cohance Lifesciences (COHANCE) market capitalisation is ₹17049.10 Cr ($1.89B), with 40.88 Cr shares outstanding at a current price of ₹417.10 on NSE, ranking 411 out of 5363 companies by market cap in our screener. Cohance Lifesciences operates in the Healthcare sector and is classified as a Mid Cap stock. View COHANCE 52-week chart for the annual high/low range and current price position.
Market Cap History of Cohance Lifesciences (Last 10 Years)
COHANCE market capitalisation from year-end NSE closing prices over the last 10 years. For live price, earnings and the complete company profile, see COHANCE stock price BSE.
End of Year Market Cap History — Cohance Lifesciences
COHANCE year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. Compare with Cohance Lifesciences valuation methods to assess whether the stock is under or overvalued.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹17049.10 Cr
$1.89B USD
|
₹417.10 | NSE | -21.09% |
| 2025 |
₹21606.70 Cr
$2.40B USD
|
₹528.60 | NSE | -53.58% |
| 2024 |
₹46546.78 Cr
$5.17B USD
|
₹1138.75 | NSE | +57.55% |
| 2023 |
₹29544.69 Cr
$3.28B USD
|
₹722.80 | NSE | +46.05% |
| 2022 |
₹20229.20 Cr
$2.25B USD
|
₹494.90 | NSE | +0.33% |
| 2021 |
₹20161.76 Cr
$2.24B USD
|
₹493.25 | NSE | +9.05% |
| 2020 |
₹18487.91 Cr
$2.05B USD
|
₹452.30 | NSE | +150666.67% |
| 2015 |
₹12.26 Cr
$1.36M USD
|
₹0.30 | NSE | - |